Thesis (Ph.D.) -- University of Rhode Island, 2008. / Typescript. Includes bibliographical references (leaves 227-239).

Thesis (M.Phil.) - University of Queensland, 2005. / Includes bibliography.

Thesis (M.S.)--Brigham Young University. Dept. of Chemical Engineering, 2005. / Includes bibliographical references (p. 101-110).

Thesis (Ph. D. (Microbiology)--University of Pretoria, 2005. / Includes bibliographical references. Available on the Internet via the World Wide Web.

Automated tracking of cells across timelapse microscopy image sequences typically employs complex segmentation routines and/or bio-staining of the tracking objective. Often accurate identification of a cell's morphology is not of interest and the accurate segmentation of cells in pursuit of non-morphological parameters is complex and time consuming. This thesis explores the potential of internalized quantum dot nanoparticles as alternative, bio- and photo-stable optical markers for tracking the motions of cells through time. CdTe/ZnS core-shell quantum dots act as nodes in moving light display networks within A549, epithelial, lung cancer cells over a 40 hour time period. These quantum dot fluorescence sources are identified and interpreted using simplistic algorithms to find consistent, non-subjective centroids that represent cell centre locations. The presented tracking protocols yield an approximate 91% success rate over 24 hours and 78% over the full 40 hours. The nanoparticle moving light displays also provide simultaneous collection of cell motility data, resolution of mitotic traversal dynamics and identification of familial relationships enabling the construction of multi-parameter lineage trees. This principle is then developed further through inclusion of 3 different coloured quantum dots to create cell specific colour barcodes and reduce the number of time points necessary to successfully track cells through time. The tracking software and identification of parameters without detailed morphological knowledge is also demonstrated through automated extraction of DOX accumulation profiles and Cobalt agglomeration accruement statistics from two separate toxicology assays without the need for cell segmentation.

No description available.

M.Sc. / The health of aquatic ecosystems can be severely compromised by a variety of pollutants, such as heavy metals, which are related to anthropogenic activities. Increased recognition is given to the use of organisms, especially molluscs, in the biomonitoring of aquatic ecosystems. This promising approach complements the interpretation of the physico-chemical measurements of water quality. The bioaccumulation of pollutants as well as the resultant biological responses (biomarkers) in organisms can be used in assessing the spatial and temporal trends of chronically polluted environments. The aim of this study was to determine if selected freshwater gastropods (Melanoides tuberculata, Physa acuta, Helisoma duryi and Lymnaea columella) can be used as suitable biomonitors or indicators of water quality. Interspecies differences in metal bioaccumulation and biomarker responses were determined in order to select the most suitable biomonitor/indicator organism to be used. The bioaccumulation of metals was related to the biomarker responses of the organisms. This study was divided into an active biomonitoring (ABM) study and a laboratory exposure study. In the first study, the organisms, M. tuberculata and L. columella were chronically (two, four and six week period) exposed to field conditions. Metal bioaccumulation as well as the biomarker techniques, DNA damage, catalase (CAT) activity, reduced glutathione (GSH) content and cellular energy allocation (CEA) were measured in the organisms. These general biomarkers of exposure and effect, on the biochemical and cellular levels of biological organisation can give a rapid and sensitive assessment of organism health. The second study consisted of exposing the gastropods, M. tuberculata, P. acuta, H. duryi and L. columella to sub-lethal zinc and cadmium concentrations. The uptake and depuration kinetics of these metals were determined in M. tuberculata and H. duryi for a six hour and 48 hour period, respectively. The bioaccumulation of Zn and Cd as well as the biomarkers, DNA damage, CAT activity, GSH content and CEA were measured in all the species, after a two week exposure period. / Prof. J.H.J. van Vuren

The theme of this dissertation is to construct heterogeneous biomarker networks using graphical models for understanding disease progression and prognosis. Biomarkers may organize into networks of connected regions. Substantial heterogeneity in networks between individuals and subgroups of individuals is observed. The strengths of network connections may vary across subjects depending on subject-specific covariates (e.g., genetic variants, age). In addition, the connectivities between biomarkers, as subject-specific network features, have been found to predict disease clinical outcomes. Thus, it is important to accurately identify biomarker network structure and estimate the strength of connections. Graphical models have been extensively used to construct complex networks. However, the estimated networks are at the population level, not accounting for subjects’ covariates. More flexible covariate-dependent graphical models are needed to capture the heterogeneity in subjects and further create new network features to improve prediction of disease clinical outcomes and stratify subjects into clinically meaningful groups. A large number of parameters are required in covariate-dependent graphical models. Regularization needs to be imposed to handle the high-dimensional parameter space. Furthermore, personalized clinical symptom networks can be constructed to investigate co-occurrence of clinical symptoms. When there are multiple biomarker modalities, the estimation of a target biomarker network can be improved by incorporating prior network information from the external modality. This dissertation contains four parts to achieve these goals: (1) An efficient l0-norm feature selection method based on augmented and penalized minimization to tackle the high-dimensional parameter space involved in covariate-dependent graphical models; (2) A two-stage approach to identify disease-associated biomarker network features; (3) An application to construct personalized symptom networks; (4) A node-wise biomarker graphical model to leverage the shared mechanism between multi-modality data when external modality data is available. In the first part of the dissertation, we propose a two-stage procedure to regularize l0-norm as close as possible and solve it by a highly efficient and simple computational algorithm. Advances in high-throughput technologies in genomics and imaging yield unprecedentedly large numbers of prognostic biomarkers. To accommodate the scale of biomarkers and study their association with disease outcomes, penalized regression is often used to identify important biomarkers. The ideal variable selection procedure would search for the best subset of predictors, which is equivalent to imposing an l0-penalty on the regression coefficients. Since this optimization is a non-deterministic polynomial-time hard (NP-hard) problem that does not scale with number of biomarkers, alternative methods mostly place smooth penalties on the regression parameters, which lead to computationally feasible optimization problems. However, empirical studies and theoretical analyses show that convex approximation of l0-norm (e.g., l1) does not outperform their l0 counterpart. The progress for l0-norm feature selection is relatively slower, where the main methods are greedy algorithms such as stepwise regression or orthogonal matching pursuit. Penalized regression based on regularizing l0-norm remains much less explored in the literature. In this work, inspired by the recently popular augmenting and data splitting algorithms including alternating direction method of multipliers, we propose a two-stage procedure for l0-penalty variable selection, referred to as augmented penalized minimization-L0 (APM-L0). APM-L0 targets l0-norm as closely as possible while keeping computation tractable, efficient, and simple, which is achieved by iterating between a convex regularized regression and a simple hard-thresholding estimation. The procedure can be viewed as arising from regularized optimization with truncated l1 norm. Thus, we propose to treat regularization parameter and thresholding parameter as tuning parameters and select based on cross-validation. A one-step coordinate descent algorithm is used in the first stage to significantly improve computational efficiency. Through extensive simulation studies and real data application, we demonstrate superior performance of the proposed method in terms of selection accuracy and computational speed as compared to existing methods. The proposed APM-L0 procedure is implemented in the R-package APML0. In the second part of the dissertation, we develop a two-stage method to estimate biomarker networks that account for heterogeneity among subjects and evaluate the network’s association with disease clinical outcome. In the first stage, we propose a conditional Gaussian graphical model with mean and precision matrix depending on covariates to obtain subject- or subgroup-specific networks. In the second stage, we evaluate the clinical utility of network measures (connection strengths) estimated from the first stage. The second stage analysis provides the relative predictive power of between-region network measures on clinical impairment in the context of regional biomarkers and existing disease risk factors. We assess the performance of the proposed method by extensive simulation studies and application to a Huntington’s disease (HD) study to investigate the effect of HD causal gene on the rate of change in motor symptom through affecting brain subcortical and cortical grey matter atrophy connections. We show that cortical network connections and subcortical volumes, but not subcortical connections are identified to be predictive of clinical motor function deterioration. We validate these findings in an independent HD study. Lastly, highly similar patterns seen in the grey matter connections and a previous white matter connectivity study suggest a shared biological mechanism for HD and support the hypothesis that white matter loss is a direct result of neuronal loss as opposed to the loss of myelin or dysmyelination. In the third part of the dissertation, we apply the methodology to construct heterogeneous cross-sectional symptom networks. The co-occurrence of symptoms may result from the direct interactions between these symptoms and the symptoms can be treated as a system. In addition, subject-specific risk factors (e.g., genetic variants, age) can also exert external influence on the system. In this work, we develop a covariate-dependent conditional Gaussian graphical model to obtain personalized symptom networks. The strengths of network connections are modeled as a function of covariates to capture the heterogeneity among individuals and subgroups of individuals. We assess the performance of the proposed method by simulation studies and an application to a Huntington’s disease study to investigate the networks of symptoms in different domains (motor, cognitive, psychiatric) and identify the important brain imaging biomarkers associated with the connections. We show that the symptoms in the same domain interact more often with each other than across domains. We validate the findings using subjects’ measurements from follow-up visits. In the fourth part of the dissertation, we propose an integrative learning approach to improve the estimation of subject-specific networks of target modality when external modality data is available. The biomarker networks measured by different modalities of data (e.g., structural magnetic resonance imaging (sMRI), diffusion tensor imaging (DTI)) may share the same true underlying biological mechanism. In this work, we propose a node-wise biomarker graphical model to leverage the shared mechanism between multi-modality data to provide a more reliable estimation of the target modality network and account for the heterogeneity in networks due to differences between subjects and networks of external modality. Latent variables are introduced to represent the shared unobserved biological network and the information from the external modality is incorporated to model the distribution of the underlying biological network. An approximation approach is used to calculate the posterior expectations of latent variables to reduce time. The performance of the proposed method is demonstrated by extensive simulation studies and an application to construct gray matter brain atrophy network of Huntington’s disease by using sMRI data and DTI data. The estimated network measures are shown to be meaningful for predicting follow-up clinical outcomes in terms of patient stratification and prediction. Lastly, we conclude the dissertation with comments on limitations and extensions.

Miniaturization, integration and intelligence are the developing trends for sensor,especially for biosensors. The development of microelectronics technology is a powerful engine to full this objective. It is well known that the microelectronic fabrication process in proven technology for fabrication of integrated circuits. Advances in the field of micro-electronics and micro-mechanical devices combined with medical science have led to the development of numerous analytical devices in monitoring of a wide range of analytes. The unique properties of nanoscale materials offer excellent prospects for interfacing biological recognition events with electronic signal transduction and for designing a new generation of bio-electronic devices exhibiting novel functions. Biosensor development has the potential to meet the need for rapid, sensitive, and specic detection of pathogenic bacteria from natural sources. This work focuses on development of one such electrochemical biosensor platform and discusses dierent aspects related to the design of biosensor and biodetection systems. A new transducer for bio sensor applications based on 3-dimensional, comb structured interdigitated electrode arrays was chosen mainly for two reasons. Firstly, this geometry allows the monitoring of both resistivity and dielectric constant of solution, thus making interdigitated electrodes more versatile tools than other kind of transducers. Second, they present short electric eld penetration depths, which make them more sensitive to changes occurring close to their surface (20 - 100 nm above the surface). This fact enables the monitoring of local changes in the vicinity of interest. Binding of analyte molecules to the chemically modied transducer surface induces important changes in the conductivity between the electrodes. Interdigitated electrodes have been employed to detect the presence of Anti-Transglutaminase (TG) antibodies, that are established biomarkers for Celiac disease which is due to gluten allergy. The biosensor was optimized for specific and sensitive detection of this biomarker. The sensor showed a sensitivity down to picomolar(pM) concentration of the biomarker. Gold nanoparticles were further used for signal enhancement so as to bring the sensor performance closer to Enzyme linked immunosorbant assay (ELISA).

No description available.